OPC-51803 Uses, Dosage, Side Effects and more
OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist. It is a V(2)-selective agonist that produces a significant antidiuretic action after single and multiple oral dosing in AVP-deficient and normal AVP states. It is useful therapeutic drug in the treatment of hypothalamic diabetes insipidus, nocturnal enuresis, and some kinds of urinary incontinence.
| Trade Name | OPC-51803 |
| Generic | OPC-51803 |
| Type | |
| Formula | C26H32ClN3O2 |
| Weight | Average: 454.004 Monoisotopic: 453.21830499 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in nocturia (frequent nighttime urination) and urinary incontinence.
